Epidermal Growth Factor in Exhaled Breath Condensate As Diagnostic Method for Non-Small Cell Lung Cancer

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2019 Sep 10

PMID 31495334

Citations 5

Authors

Jinliang Chen

Jianrong Chen

Xuedong Lv

Qichang Yang

Sumei Yao

Affiliations

Soon will be listed here.

Abstract

Objective: Lung cancer is one of the most common malignant tumors in humans. Finding a highly sensitive and specific marker is very important. This study investigated the clinical significance of epidermal growth factor in exhaled breath condensate and serum of patients with non-small cell lung cancer.

Methods: From October 17, 2013, to June 5, 2017, exhaled breath condensate and blood samples from 155 patients with non-small cell lung cancer, 63 patients with benign pulmonary nodules, and 115 healthy controls were collected using a breath condenser. Each sample was analyzed by enzyme-linked immunosorbent assay.

Results: Epidermal growth factor level in the exhaled breath condensate from the non-small cell lung cancer group (197.86 ± 60.67 pg/mL) was higher than that in the healthy group (124.75 ± 36.09 pg/mL), < .05. Epidermal growth factor level in the exhaled breath condensate of the smoking group (208.85 ± 40.94 pg/mL) was higher than that of the nonsmoking group (185.52 ± 36.88 pg/mL), < .05. Epidermal growth factor level in the exhaled breath condensate in phases III and IV of non-small cell lung cancer group (212.17 ± 35.41 pg/mL) was higher than that in phases I and II (173.91 ± 38.08 pg/mL), < .05. Epidermal growth factor level in the exhaled breath condensate of the death group (241.05 ± 27.19 pg/mL) was higher than that of the survival group (188.75 ± 37.07 pg/mL), < .05. The epidermal growth factor exhaled breath condensate levels were positively correlated with the serum epidermal growth factor levels with a correlation coefficient of 0.495 ( < .05). The sensitivity and specificity of epidermal growth factor exhaled breath condensate test were 80.0% and 89.6%, respectively.

Conclusion: The detection of epidermal growth factor level in exhaled breath condensate exhibits is important in the diagnosis, disease monitoring, and prognosis of non-small cell lung cancer.

Citing Articles

The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

Kita K, Gawinowska M, Chelminska M, Niedoszytko M Int J Mol Sci. 2024; 25(13).

PMID: 39000502 PMC: 11242091. DOI: 10.3390/ijms25137395.

Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study.

Meng L, Cao J, Kang L, Xu G, Yuan D, Li K Pharmgenomics Pers Med. 2023; 16:1027-1039.

PMID: 38046381 PMC: 10693251. DOI: 10.2147/PGPM.S432528.

Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study.

Li X, Zhang W, Li M, Wang J, Lian J, Zhou H J Oncol. 2022; 2022:1710272.

PMID: 35909903 PMC: 9337937. DOI: 10.1155/2022/1710272.

Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study.

Jiang H, Li W, Zhang B, Gong Q, Qie H Int J Gen Med. 2021; 14:7625-7637.

PMID: 34754233 PMC: 8572099. DOI: 10.2147/IJGM.S334436.

Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer.

Xie H, Chen J, Lv X, Zhang L, Wu J, Ge X Technol Cancer Res Treat. 2020; 19:1533033820947490.

PMID: 32851926 PMC: 7457640. DOI: 10.1177/1533033820947490.

References

Inoue K, Torimura T, Nakamura T, Iwamoto H, Masuda H, Abe M . Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice. Clin Cancer Res. 2012; 18(14):3924-33. DOI: 10.1158/1078-0432.CCR-11-2041. View

Youssef O, Aija Knuuttila , Piirila P, Bohling T, Sarhadi V, Knuutila S . Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing. Oncotarget. 2017; 8(11):18166-18176. PMC: 5392316. DOI: 10.18632/oncotarget.15233. View

Hayes S, Haefliger S, Harris B, Pavlakis N, Clarke S, Molloy M . Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. J Breath Res. 2016; 10(3):034001. DOI: 10.1088/1752-7155/10/3/034001. View

Peralbo-Molina A, Calderon-Santiago M, Priego-Capote F, Jurado-Gamez B, Luque de Castro M . Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals. J Breath Res. 2016; 10(1):016011. DOI: 10.1088/1752-7155/10/1/016011. View

Dassanayake D, Muthunayake T, Senevirathna K, Siribaddana A . Staging of lung cancer in a tertiary care setting in Sri Lanka, using TNM 7th edition. A comparison against TNM6. BMC Res Notes. 2012; 5:143. PMC: 3327630. DOI: 10.1186/1756-0500-5-143. View

Brueckl W, Schoeberl A, Wirtz R, Murray S, Hahn E, Wiest G . Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC). J Thorac Oncol. 2008; 3(3):314-6. DOI: 10.1097/JTO.0b013e3181654423. View

Ahmed N, Bezabeh T, Ijare O, Myers R, Alomran R, Aliani M . Metabolic Signatures of Lung Cancer in Sputum and Exhaled Breath Condensate Detected by H Magnetic Resonance Spectroscopy: A Feasibility Study. Magn Reson Insights. 2016; 9:29-35. PMC: 5117486. DOI: 10.4137/MRI.S40864. View

Wu Z, Tian Y, Yu Q, Li H, Tian Z, Jiang H . The expression and correlation between chemokine CCL7 and ABCE1 in non-small cell lung cancer. Exp Ther Med. 2018; 16(4):3004-3010. PMC: 6125957. DOI: 10.3892/etm.2018.6568. View

Smyth R, Toomey S, Sartori A, OHanrahan E, Cuffe S, Breathnach O . Brief Report on the Detection of the EGFR T790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients. J Thorac Oncol. 2018; 13(8):1213-1216. DOI: 10.1016/j.jtho.2018.04.033. View

10.

Zuo W, Yang J, Gomi K, Chao I, Crystal R, Shaykhiev R . EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium. Stem Cells. 2016; 35(3):824-837. PMC: 5330845. DOI: 10.1002/stem.2512. View

11.

Xiao P, Chen J, Zhou F, Lu C, Yang Q, Tao G . Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. Lung Cancer. 2013; 83(1):56-60. DOI: 10.1016/j.lungcan.2013.09.008. View

12.

Krawczyk A, Nowak D, Nowak P, Padula G, Kwiatkowska S . Elevated exhalation of hydrogen peroxide in patients with non-small cell lung cancer is not affected by chemotherapy. Redox Rep. 2016; 22(6):308-314. PMC: 6837449. DOI: 10.1080/13510002.2016.1229885. View

13.

Peralbo-Molina A, Calderon-Santiago M, Priego-Capote F, Jurado-Gamez B, Luque de Castro M . Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate. J Breath Res. 2016; 10(2):026002. DOI: 10.1088/1752-7155/10/2/026002. View

14.

Carpagnano G, Lacedonia D, Natalicchio M, Cotugno G, Zoppo L, Martinelli D . Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV. Clin Respir J. 2016; 12(2):418-424. DOI: 10.1111/crj.12531. View

15.

Carpagnano G, Lacedonia D, Crisetti E, Martinelli D, Foschino-Barbaro M . New panel of microsatellite alterations detectable in the EBC for lung cancer prognosis. J Cancer. 2016; 7(15):2266-2269. PMC: 5166536. DOI: 10.7150/jca.15921. View

16.

Lopez-Sanchez L, Jurado-Gamez B, Feu-Collado N, Valverde A, Canas A, Fernandez-Rueda J . Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. Am J Physiol Lung Cell Mol Physiol. 2017; 313(4):L664-L676. DOI: 10.1152/ajplung.00119.2017. View

17.

Chen J, Lv X, Ma H, Chen J, Huang J . Detection of cancer embryo antigen and endothelin-1 in exhaled breath condensate: A novel approach to investigate non-small cell lung cancer. Mol Clin Oncol. 2016; 5(1):124-128. PMC: 4906950. DOI: 10.3892/mco.2016.902. View

18.

Youssef O, Sarhadi V, Armengol G, Piirila P, Aija Knuuttila , Knuutila S . Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review. Genes Chromosomes Cancer. 2016; 55(12):905-914. DOI: 10.1002/gcc.22399. View

19.

Romero-Ventosa E, Blanco-Prieto S, Gonzalez-Pineiro A, Rodriguez-Berrocal F, Pineiro-Corrales G, Paez de la Cadena M . Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients. Springerplus. 2015; 4:171. PMC: 4402684. DOI: 10.1186/s40064-015-0891-0. View